Training and Education

EVO NXT will restart on 5th an 6th April

Following the successful début in Málaga last year, preparations for the second EVO NXT Business Festival for next-generation products (NGPs) are in full swing. In its four zones, EVO NXT is not only going to provide a comprehensive overview of all...

Combination detector reveals essential macromolecular properties

TESTA Analytical report how its COMBO-TWO MALS/DRI combination detector for Gel Permeation Chromatography (GPC) is helping biopharmaceutical and advanced materials researchers unlock essential macromolecular physical properties including molecular weight, structure, and conformation. The baseline signal stability of any GPC detector...

Products and Services for Diversifying Preclinical Models

AMSBIO has expanded its range of products and services dedicated to assisting scientists diversify their preclinical models effectively to help bridge the gender discrepancy gap in many areas of research. Until 1993, most clinical trial participants were men of European...

2nd Accelerator Programme open for applications

Launched in 2023 and funded by the UKRI Technology Missions Fund, Science Creates Accelerate has also embarked on a new partnership with globally recognised VCs to support a second cohort of deep tech entrepreneurs. Science Creates Accelerate, launched last year...

Novel reagents advance research into Parkinsons disease and sleep disorders

In a recent blog post – AMSBIO describe how life science research groups are using their BioPORTER®, Detachin™, and SoluLyse™ reagents to make groundbreaking advances in Parkinson’s research, hypersomnia studies and eco-friendly microbial ester production. These novel reagents empower research...

EVO NXT will restart on 5th an 6th April

Following the successful début in Málaga last year, preparations for the second EVO NXT Business Festival for next-generation products (NGPs) are in full swing. In its four zones, EVO NXT is not only going to provide a comprehensive overview of all...

Leading Biotech lab selling existing equipment and facilities to move to larger premises to absorb business growth

WorldPathol, a biotechnology holding based on the research and development of highly specialised biological products such as veterinary vaccines, new recombinant active ingredients, novel medical devices, as well as state-of-the-art cosmetics and nutraceuticals, has commissioned SURUS to sell its...

Expanded Stem Cell Synergy Solutions

AMSBIO, a leading provider of innovative products and services for the life sciences community, announces the launch of its Expanded Stem Cell Synergy Solutions. Over the last two decades AMSBIO has established itself as a leading international supplier of solutions...

Certification for Liquid Flowmeters

TESTA Analytical offers a choice of certification services to demonstrate the reliability and quality of each Liquid Chromatography flowmeter or microflowmeter it delivers to a customer lab. All flowmeters come with a free Certificate of Conformity demonstrating compliance of each...

Norwich Research Park start-up Ikarovec sets its sight on preventing blindness

Ikarovec is a pioneering gene therapy start-up, based at Norwich Research Park, that is committed to the development of cutting-edge treatments to address the unmet clinical needs of individuals with chronic eye diseases, such as age-related macular degeneration (AMD). ...

Scottish biopharma company’s state-of-the-art technology attracts £730k in fresh investment

Scottish biopharmaceutical company Aurum Biosciences has raised almost £730,000 in the first tranche of a new round of equity funding aimed at further developing its state-of-the-art therapeutic and diagnostic technology and setting up fresh success in 2024. The funding round – which will be split across...

Angstrom Technology provides full suite of cleanroom services for Plexus Corp.

Angstrom Technology was appointed to work alongside Plexus Corp, fulfilling their brief to design and build a new cleanroom facility for manufacturing components for their customer within the semiconductor industry. The Client Plexus is a global organisation that is contracted by...

Llamas: leading the pack in new cancer therapy

Llama antibodies - known as VHHs or nanobodies - could be a gamechanger for precision medicine. Marion Cubitt, Director of Discovery at Isogenica, explains how an accidental discovery opened a fresh pathway for immunotherapy. Tell us about Isogenica’s work Isogenica are...

Navigating the 2024 life science landscape: trends, challenges, and opportunities

As we step into 2024, the global life science industry finds itself at a crossroads, facing plenty of challenges and exciting opportunities, says Emma Banks, CEO, ramarketing. The pharmaceutical and contract outsourcing space has shifted, with new trends emerging that...

UK leads Europe in cell and gene therapy

The UK is cementing its position as a global leader in cell and gene therapy, according to new data A report by the UK BioIndustry Association (BIA), in collaboration with Citeline, reveals a robust sector with significant investment, the highest...

SRM (Strategic Resource Management) can help you harness the full power of your data

In the contemporary business landscape, data has emerged as a key asset, serving as the lifeblood that drives decision-making and strategic planning. The 2020s have ushered in an era where businesses are inundated with a wealth of data from diverse...

Unravelling the DNA dilemma: A new chapter in rare disease research

‘Hope is not lost’ for the 50 per cent of people with undiagnosed rare diseases, says UK genomics expert Neil Ward, of PacBio. New technologies can provide more accurate, in-depth data on the genome, and help reveal the underlying...

Brain scan tech takes major step forward

Advanced MRI scanners being developed by University of California Berkeley will allow doctors and scientists to see the brain in greater detail than ever before, which could lead to ground-breaking treatments for brain disorders such as degenerative diseases, schizophrenia...

Major study describes brain pathology of domestic violence

A major international brain autopsy study of women who had experienced intimate partner violence reveals substantial damage in the brain, but no evidence of chronic traumatic encephalopathy (CTE), the neurodegenerative disease recognised among contact sports athletes who sustain repeated...

UK firm plans state-of-the-art precision medicine centre in California

Working with local partners, BIOS Health, of Cambridge, will create a cutting-edge research and clinical trials center for neural digital therapies. The centre will be built around BIOS’s real-time insights into the nervous system, which provides crucial data previously...

NETPark: A Catalyst for Job Creation and Economic Prosperity

The year 2023 was a landmark year for the North East Technology Park (NETPark) at Sedgefield, as it embarked on a £61 million expansion, marking a significant milestone in its development.  This expansion, led by Durham County Council, is set...

Study paves the way for new cirrhosis treatments

The world’s most extensive clinical study into liver cirrhosis has been announced by Newcastle University, University of Edinburgh and r esearch-driven global biopharmaceutical company, Boehringer Ingelheim. The ADVANCE (Accelerating Discovery: Actionable NASH Cirrhosis Endpoints) study will be the most detailed...

£13m disease early warning system for England to open at University of Bath

Water-based community health monitoring Centre of Excellence will detect disease outbreaks. A new £13 million Centre of Excellence in water-based health monitoring will be established at the University of Bath following a major funding award. The Centre of Excellence in Water-Based...

Bacterial Biofilms: A game-changer in the battle against infection

Bacteria, those tiny, often-misunderstood microorganisms, have revealed a groundbreaking secret that could transform our approach to combating infections. Luiza Beirão Campos, of the European Science Communication Institute (ESCI), explains how. Bacteria are notorious for banding together and       ...

Rejoining Horizon: Spotlighting the importance of international collaboration

On 1 January 2024, the UK re-entered Horizon Europe through a bespoke EU agreement. Dr Harshil Patel, Head of Scientific Development, Seqera Labs, celebrates the landmark return. Tackling the challenges facing humanity in the 21st century requires international collaboration that...

Improved radionuclide supply can transform nuclear medicine

Targeted Alpha Therapy (TAT) is a promising cancer treatment in nuclear medicine, but the supply of alpha-emitting radionuclides - which the treatment relies on - is very limited. A lack of alpha-emitting radionuclides in the UK is preventing research...

Growing microtumours in a dish hailed as ‘rapid way to identify tumour genes’

Researchers have identified a new way to screen genes that cause several different types of cancers to grow, identifying particularly promising targets for precision oncology in oral and esophageal squamous cancers. The study, published in Cell Reports, used 3-dimensional models...

Why does puberty trigger us to stop growing?

Fruit flies could provide new insights into human development, writes Emily Stone, of the University of Illinois. All animals start out as a single-celled organism and then start growing. At some point, of course, they need to stop getting bigger, but...

Are we alone in the Universe … is this the big REVEAL?

In the search for life-friendly exoplanets, researchers from the University of St Andrews, Germany and the USA join forces in a pioneering €9.5M European Research Council funded project. The joint research project REVEAL (Revealing Signatures of Habitable Worlds Hidden by...

UK start-up to develop tech for pharma factory in space

A start-up is developing technology to build a pharmaceuticals factory in space that could help improve the lives of patients undergoing antibody treatments for cancer and other diseases. Currently, for patients undergoing antibody cancer treatments, this involves spending hours at...